Perseus Proteomics Inc. [4882.T]
TOKYO, Apr 15 (Pulse News Wire) – Perseus Proteomics Inc. (4882.T) resolved to issue equity-based stock options to its executives and employees at a board meeting held .
The move aims to align their interests more closely with those of shareholders by exposing them to both upside gains and downside risks associated with share price movements. Under the plan, the company will issue 1,237 stock options, allowing recipients to acquire up to 123,700 common shares upon exercise. Each option grants the right to purchase 100 shares at an exercise price of ¥1,000 per share.
Exercise periods begin on May 1, 2027, and end on April 30, 2036, subject to vesting conditions tied to tenure. Executives who lose their positions due to reasons deemed unjustifiable by the board will forfeit unvested options. Additionally, the company reserves the right to repurchase unexercised options in certain organizational restructuring scenarios.
On April 21, 2026, Perseus Proteomics assigned 280 options to three non-executive directors and 957 options to 31 employees.
🟡 Confidence: Standard AI-translated content.